Literature DB >> 22644836

Insulin resistance is not necessarily an essential element of metabolic syndrome.

Rudruidee Karnchanasorn1, Horng-Yi Ou, Lee-Ming Chuang, Ken C Chiu.   

Abstract

Type 2 diabetes is frequently associated with metabolic syndrome (MetS). Insulin resistance (IR) is thought to be the underlying pathophysiology of MetS. The purpose of this study is to examine the association of MetS with IR and beta cell function. This is a cross-sectional study in NHANES 1999-2000 participants who were at least 18 years old, including 911 non-Hispanic whites (NHW), 398 non-Hispanic blacks (NHB), and 595 Mexican-Americans (MA). MetS was defined based on the revised ATP III. IR and beta cell function were calculated using homeostasis model assessment (HOMA-IR and HOMA-B). The high-risk tertile was defined as the highest HOMA-IR and lowest HOMA-B. The odds ratio (OR) was calculated against the other two tertiles. The relationship of HOAM-IR and HOMA-B with the components of MetS was also examined. IR was a risk factor of MetS in all three ethnic groups (OR 4.17-12.01, P < 0.0001). Fasting glucose, triglycerides, and HDL cholesterol were associated with IR (P < 0.001) and correlated with HOMA-IR (P < 0.001), while inconsistent results were noted in blood pressure and waist circumference among three racial/ethnic groups. However, in the MetS subjects, 32 % of NHW, 28 % of NHB, and 44 % of MA were not in the IR tertile and in the IR subjects, 25 % of NHW, 36 % NHB, and 30 % of MA did not have MetS. No relationship was found between beta cell function and MetS. Although IR is a risk factor for MetS, IR is neither necessary nor required for MetS.

Entities:  

Mesh:

Year:  2012        PMID: 22644836     DOI: 10.1007/s12020-012-9702-3

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  45 in total

Review 1.  Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes.

Authors:  S E Kahn
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

2.  Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study.

Authors:  J B Meigs; R B D'Agostino; P W Wilson; L A Cupples; D M Nathan; D E Singer
Journal:  Diabetes       Date:  1997-10       Impact factor: 9.461

3.  Insulin and blood pressure: fact or fantasy?

Authors:  S M Haffner
Journal:  J Clin Endocrinol Metab       Date:  1993-03       Impact factor: 5.958

4.  Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes.

Authors:  M P Hermans; J C Levy; R J Morris; R C Turner
Journal:  Diabetologia       Date:  1999-06       Impact factor: 10.122

5.  Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study.

Authors:  Martin K Rutter; James B Meigs; Lisa M Sullivan; Ralph B D'Agostino; Peter W Wilson
Journal:  Diabetes       Date:  2005-11       Impact factor: 9.461

Review 6.  Insulin resistance in obesity as the underlying cause for the metabolic syndrome.

Authors:  Emily J Gallagher; Derek Leroith; Eddy Karnieli
Journal:  Mt Sinai J Med       Date:  2010 Sep-Oct

7.  Relationship of plasma insulin concentration and insulin sensitivity to blood pressure. Is it modified by obesity?

Authors:  L Mykkanen; S M Haffner; T Ronnemaa; R M Watanabe; M Laakso
Journal:  J Hypertens       Date:  1996-03       Impact factor: 4.844

Review 8.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  Richard Kahn; John Buse; Ele Ferrannini; Michael Stern
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

Review 9.  Insulin resistance syndrome, pre-diabetes, and the prevention of type 2 diabetes mellitus.

Authors:  Deirdre O Smith; Derek LeRoith
Journal:  Clin Cornerstone       Date:  2004

Review 10.  Diabetes and cardiovascular disease. The "common soil" hypothesis.

Authors:  M P Stern
Journal:  Diabetes       Date:  1995-04       Impact factor: 9.461

View more
  5 in total

1.  C-reactive protein concentration as a significant correlate for metabolic syndrome: a Chinese population-based study.

Authors:  Tsan Yang; Chi-Hong Chu; Po-Chien Hsieh; Chih-Hsung Hsu; Yu-Ching Chou; Shih-Hsien Yang; Chyi-Huey Bai; San-Lin You; Lee-Ching Hwang; Tieh-Chi Chung; Chien-An Sun
Journal:  Endocrine       Date:  2012-07-19       Impact factor: 3.633

Review 2.  Hepatic function and the cardiometabolic syndrome.

Authors:  Nicolas Wiernsperger
Journal:  Diabetes Metab Syndr Obes       Date:  2013-10-10       Impact factor: 3.168

3.  Application of Latent Class Analysis to Identify Metabolic Syndrome Components Patterns in adults: Tehran Lipid and Glucose study.

Authors:  Noushin Sadat Ahanchi; Farzad Hadaegh; Abbas Alipour; Arash Ghanbarian; Fereidoun Azizi; Davood Khalili
Journal:  Sci Rep       Date:  2019-02-07       Impact factor: 4.379

Review 4.  Influence of Cardiometabolic Risk Factors on Platelet Function.

Authors:  Cristina Barale; Isabella Russo
Journal:  Int J Mol Sci       Date:  2020-01-17       Impact factor: 5.923

Review 5.  The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balance.

Authors:  Isabella Russo
Journal:  Scientifica (Cairo)       Date:  2012-08-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.